Home > Perspectives on drugs: The misuse of benzodiazepines among high-risk opioid users in Europe.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2015) Perspectives on drugs: The misuse of benzodiazepines among high-risk opioid users in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 8 p.

[img]
Preview
PDF (The misuse of benzodiazepines among high-risk opioid users in Europe)
488kB

URL: http://www.emcdda.europa.eu/topics/pods/benzodiaze...

Benzodiazepines are a widely prescribed group of medicines with a range of clinical uses, including the treatment of anxiety and insomnia and the management of alcohol withdrawal. For a number of reasons this group of medicines are often misused by high-risk opioid users and are associated with morbidity and mortality among this group. This analysis considers the significance of this problem and its impact for the health and drug treatment of opioid users.

Part of the Perspectives on Drugs (PODs) series, launched as part of the European Drug Report package, these designed-for-the-web interactive analyses provide deeper insights into a selection of important issues.


Item Type:Evidence resource
Publication Type:Review
Drug Type:CNS depressants, Opioid, Prescription/Over the counter
Intervention Type:AOD disorder, AOD disorder harm reduction
Source:EMCDDA
Date:June 2015
Pages:8 p.
Publisher:European Monitoring Centre for Drugs and Drug Addiction
Corporate Creators:European Monitoring Centre for Drugs and Drug Addiction
Place of Publication:Lisbon
EndNote:View
Subjects:B Substances > Sedatives or tranquillisers (CNS depressants) > Benzodiazepine
B Substances > Opioids (opiates)
E Concepts in biomedical areas > Substance by legal status > Prescription drug (medicine / medication)
F Concepts in psychology > Specific attitude and behaviour > risk-taking behaviour
G Health and disease > Substance use disorder > Multiple substance use (Poly-drug /Poly-substance)
VA Geographic area > Europe

Repository Staff Only: item control page